FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

11047611000001103: Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
37624601000001119 Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
96051301000001114 Suboxone 2mg/500microgram sublingual tablets (Indivior UK Ltd) 28 tablet 4 x 7 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register) true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Naloxone hydrochloride dihydrate true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Is a Buprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar free 28 tablet true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Is pack of Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) false Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has active ingredient Buprenorphine hydrochloride false Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has active ingredient Naloxone hydrochloride false Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has manufactured dose form Conventional release sublingual tablet false Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has AMP Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naloxone false Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Buprenorphine hydrochloride true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Naloxone hydrochloride false Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has dispensed dose form Conventional release sublingual tablet true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has basis of strength substance Naloxone true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has basis of strength substance Buprenorphine true Inferred relationship Existential restriction modifier
Suboxone 2mg/500microgram sublingual tablets (Schering-Plough Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Naloxone hydrochloride dihydrate false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start